184 related articles for article (PubMed ID: 31129597)
1. Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis.
Kamiya H; Panlaqui OM
BMJ Open; 2019 May; 9(5):e028226. PubMed ID: 31129597
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review.
Kamiya H; Panlaqui OM
BMJ Open; 2018 Mar; 8(3):e020862. PubMed ID: 29523572
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis.
Kamiya H; Panlaqui OM
BMJ Open; 2020 Jun; 10(6):e035420. PubMed ID: 32540889
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis.
Kamiya H; Panlaqui OM; Izumi S; Sozu T
BMJ Open; 2016 Nov; 6(11):e012744. PubMed ID: 27856478
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
Kamiya H; Panlaqui OM
BMC Pulm Med; 2020 Mar; 20(1):57. PubMed ID: 32122329
[TBL] [Abstract][Full Text] [Related]
7. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features.
Kamiya H; Panlaqui OM
BMJ Open; 2019 Dec; 9(12):e031444. PubMed ID: 31831537
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Qiu M; Chen Y; Ye Q
Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
[TBL] [Abstract][Full Text] [Related]
10. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
[TBL] [Abstract][Full Text] [Related]
12. Effect of home-based pulmonary rehabilitation on functional capacity in people with idiopathic pulmonary fibrosis-a systematic review protocol.
Amin R; Vaishali K; Maiya GA; Mohapatra AK; Yadav UN; Parsekar SS
Syst Rev; 2021 Nov; 10(1):297. PubMed ID: 34782011
[TBL] [Abstract][Full Text] [Related]
13. Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.
Li DY; Liu X; Huang JY; Hang WL; Yu GR; Xu Y
Ther Adv Respir Dis; 2024; 18():17534666241232561. PubMed ID: 38414439
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors associated with mortality in acute exacerbations of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Pitre T; Lupas D; Ebeido I; Colak A; Modi M; Kachkovski GV; Montesi SB; Khor YH; Kawano-Dourado L; Jenkins G; Fisher JH; Shapera S; Rochwerg B; Couban R; Zeraatkar D
Respir Med; 2024 Feb; 222():107515. PubMed ID: 38154738
[TBL] [Abstract][Full Text] [Related]
15. Multiple Traditional Chinese Medicine interventions for idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview.
Zhang HY; Pang LJ; Lv XD; Liu C; Nan MH
Medicine (Baltimore); 2020 Sep; 99(39):e22396. PubMed ID: 32991463
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.
Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H
Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview.
Li LJ; Chen X; Yang WN; Xu XM; Lu LY; Wang J; Kong YX; Zheng JH
Medicine (Baltimore); 2020 Jul; 99(31):e21310. PubMed ID: 32756114
[TBL] [Abstract][Full Text] [Related]
18. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the unmet needs of patients diagnosed with idiopathic pulmonary fibrosis: a scoping review protocol.
Bramhill C; Langan D; Mulryan H; Eustace-Cook J; Russell AM; Brady AM
BMJ Open; 2023 May; 13(5):e070513. PubMed ID: 37130693
[TBL] [Abstract][Full Text] [Related]
20. Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Petnak T; Lertjitbanjong P; Thongprayoon C; Moua T
Chest; 2021 Nov; 160(5):1751-1763. PubMed ID: 34217681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
